CD99, CD99 molecule (Xg blood group), 4267

N. diseases: 197; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.050 Biomarker disease BEFREE Histopathological findings showed neuroblastoma and immunohistochemical results were as follows: actin(-), CD34(-), CD99(-), CK(-), CgA(+), desmin(-), EMA(-), Ki-67(+, approximately 1%), NSE(+), S-100(+), Syn(+), and vimentin(-). 30572519 2018
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.050 AlteredExpression disease BEFREE It is one of the pediatric small round blue cell tumors, characterized by strong membrane expression of CD99 in a chain-mail pattern and negativity for lymphoid (CD45), rhabdomyosarcoma (myogenin, desmin, actin) and neuroblastoma (neurofilament protein) markers. 16720851 2006
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.050 GeneticVariation disease BEFREE Nonmyogenic markers included: vimentin (100%), CD99 (16%), p53 (16%), pancytokeratin (10%), NSE (8%), LCA (6%), CD20 (6%), EMA (2%), and NB-84 (0%, neuroblastoma). 12110339 2002
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.050 Biomarker disease BEFREE Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT. 7571088 1995
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.050 Biomarker disease BEFREE Use of HBA 71 and anti-beta 2-microglobulin to distinguish peripheral neuroepithelioma from neuroblastoma. 8375858 1993